A new market study, titled “Site-Specific Drug Delivery Market, By Application (Pulmonary, Ocular, Oncology, CNS, Cardiovascular) – World Forecasts to 2022”, has been featured on WiseGuyReports.
The advent of site specific/targeted drug delivery has revolutionized the drug delivery industry. This technique is allowing a previously unattainable level of drug delivery with greater efficiency to target organs and tissues. Due to this ability, the share of site specific drug delivery is incessantly increasing in the drug delivery industry. It is anticipated that the global site specific drug delivery market will cross US$ 114 Billion by 2022. The growth of the market is likely to be driven by expanding drug discovery applications, rising chronic disease incidences, and increasing research related activities for exploring drug delivery therapeutic applications.
The report, “Site-Specific Drug Delivery Market, By Application (Pulmonary, Ocular, Oncology, CNS, Cardiovascular) – World Forecasts to 2022”, provides an insight into the current and future prospective of this market. This report covers the major opportunities in this area, and drivers that have impact on the market. The report also discusses some of the challenges currently faced by the market.
The major application areas of targeted drug delivery pulmonary, ocular, oncology, and others including CNS, cardiovascular, etc. Oncology based application is the largest area of application of targeted drug delivery. This large share can be attributed to various research related activities conducted for developing targeted drug delivery approach for cancer.
Moreover, the report also contains the market share of major regions, including North America, Europe, and Asia Pacific. North America holds the largest market share, while Asia Pacific is expected to witness highest growth in the coming years, i.e. 2016-2022. The major reasons for the high growth are the ongoing researches in China and Australia, which is expanding therapeutic applications of site specific drug delivery to brain disorders. North America and Europe are expected to grow at a modest rate due to less stringent regulatory approval process and advancements in drug delivery technique.
The last segment of the report is entirely devoted to profiling leading companies of the targeted drug delivery industry, including some major players like Celgene Corporation, Arrowhead Pharma, Intezyne, Endocyte, BioDelivery Sciences International, PharmaIN, Mirus Bio, Savara, etc. This segment provides access to the financials, product portfolio, and recent developments of these companies. This segment also discusses the strengths and weaknesses of key players in this industry. Overall, the research contains exhaustive information that will help clients in formulating market strategies and assessing opportunity areas in the global site specific drug delivery market.
Request Sample Report at https://www.wiseguyreports.com/sample-request/1706485-site-specific-drug-delivery-market-by-application-pulmonary-ocular-oncology-cns
Table of Content
- Analyst View
- Research Methodology
- Introduction to Site-Specific Drug Delivery
- Market Dynamics
- Global Site-Specific Drug Delivery Market Outlook to 2022
- Site-Specific Drug Delivery Market by Application
- Site-Specific Drug Delivery Market by Geography
- Trends & Developments
- Mergers, Acquisitions, & Collaborations
- Company Profiles
10.1 Celgene Corporation
10.2 Arrowhead Pharmaceuticals, Inc.
10.3 BioDelivery Sciences International, Inc.
10.4 Endocyte, Inc.
10.5 Intezyne, Inc.
10.6 PharmaIN
10.7 Kurve Technology, Inc.
10.8 Mirus Bio LLC.
10.9 Savara Inc.
10.10 Delpor, Inc.
About Us:
Wise Guy Reports is part of the Wise Guy Research Consultants Pvt. Ltd. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe.
Contact Us:
NORAH TRENT
Ph: +1-646-845-9349 (US)
Ph: +44 208 133 9349 (UK)
